Voyages pour PME Mission économique et commerciale de la Francophonie en Amérique du Nord 11 juin 2024–13 juin 2024
News 04 avr 2024 Legartis and Implenia automate contract reviews in the construction industry Legartis and Implenia are aiming to shorten the amount of time spent reviewing comprehensive contracts in the construction industry. Legartis, wh...
Aktuell 11 déc 2023 Fünf Start-ups schaffen es in die finale Phase von DayOne Health 4.0 Die Jury hat die fünf internationalen Healthtech-Start-ups für die finale Phase von DayOne Health 4.0 gewählt, darunter das Berner Start-up machi...
Aktuell 15 avr 2024 Erster BOOM Summit war erfolgreich Die Veranstalter des BOOM Summit bezeichnen die Premiere als gelungen. Auf der Basler Gesundheitskonferenz tauschten 500 Fachleute am 10. und 11....
News 15 avr 2024 First BOOM Summit deemed a success The organizers of the BOOM Summit are describing the first edition as a success. In total, 500 experts exchanged their knowledge and expertise at...
News 24 mai 2024 Geistlich receives EU certification for collagen portfolio Geistlich Pharma has received MDR certification for its collagen product range and thus meets the new EU requirements. The products will be used ...
News 11 déc 2023 Five startups advance to final phase of DayOne Health 4.0 Five international healthcare startups – including the Bern-based startup machineMD – have made it to the final phase of DayOne Health 4.0. With ...
Novità 05 déc 2022 Industry 4.0 nel cuore dell'innovazione svizzera Con le sue aziende, gli istituti e i centri di ricerca attivi nel campo dell'Industria 4.0, la Svizzera dispone di risorse eccellenti per sfrutta...
News 24 mai 2024 Health Innovation Hub drives medical innovation Switzerland Innovation Park East has opened its Health Innovation Hub in St.Gallen. The hub serves as a platform for initiating, promoting and ac...
News 10 mai 2024 BioVersys extends Series C financing round to 44.9 million Swiss francs BioVersys is bolstering its partnership with GSK in order to accelerate the development of alpibectir for the treatment of tuberculosis. GSK is s...
News 21 nov 2022 Industry 4.0 at the heart of Swiss innovation With its companies, institutes, and research centers active in the field of Industry 4.0, Switzerland has excellent resources to exploit the pote...
News 30 avr 2024 Top Stories from Western Switzerland (April 2024) From biotech breakthroughs and the transformation of clinical trials to advancements in eco-friendly materials and renewable energy initiatives, ...
Success stories 23 avr 2024 How BeiGene drives global cancer treatment access From its European headquarters in Basel, Switzerland, BeiGene strategically collaborates with stakeholders worldwide to advance oncology research...
News 30 avr 2024 Johnson & Johnson opens Innovation Hub in Allschwil Johnson & Johnson has opened its first J&J Innovation Hub on the European mainland at the Switzerland Innovation Park Basel Area. This represents...
News 11 oct 2023 EPFL’s CIS for the development of intelligent systems In Lausanne, the EPFL's Center for Intelligent Systems melds AI, robotics, and interdisciplinary research, fostering a realm of innovation and co...
Actualités 21 nov 2022 L’industrie 4.0 au centre de l’innovation suisse Avec ses entreprises, instituts et centres de recherche actifs dans le domaine de l’industrie 4.0, la Suisse détient d’excellentes ressources pou...
News 25 avr 2024 Swiss biotech achieves record revenues in 2023 Swiss biotech companies generated record revenues of 7.3 billion Swiss francs in 2023, while capital investments rose 50 per cent year on year to...
News 17 avr 2024 Addex Therapeutics launches spin-off Neurosterix in Geneva with USD 63 million investment Geneva's Addex Therapeutics has teamed up with Perceptive Advisors to launch spin-off Neurosterix, a new player in neurology-focused drug develop...